REFERENCE
US FDA.FDA Drug Safety Communication: Seizure risk for multiple sclerosis patients who take Ampyra (dalfampridine). Internet Document: [2 pages], 23 Jul 2012. Available from: URL: http://www.fda.gov
Rights and permissions
About this article
Cite this article
FDA warns of seizure risk with dalfampridine. React. Wkly. 1412, 2 (2012). https://doi.org/10.2165/00128415-201214120-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128415-201214120-00004